Temozolomide and the PARP Inhibitor Niraparib Enhance Expression of Natural Killer Group 2D Ligand ULBP1 and Gamma-Delta T Cell Cytotoxicity in Glioblastoma
Article in Cancers (August 2024)
The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.
Article in Cancers (August 2024)
Article in Frontiers in Pharmacology (July 2024)
Article in Animal Cells and Systems (May 2024)